Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

For more information
on BPDCN, click here



The Company
Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk.
Clinical Trials
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen to identify novel compounds that target and kill CSCs.


News
&
Events
8/23/2016
Stemline Receives Breakthrough Therapy Designation from U.S. FDA
8/11/2016
Stemline to Present at the 2016 Wedbush PacGrow Healthcare Conference
8/4/2016
Stemline Reports 2Q16 Financial Results and Highlights Recent Clinical Progress
Copyright 2016 - Stemline Therapeutics, Inc. All rights reserved
Stemline